Health Care & Life Sciences » Pharmaceuticals | DAE HWA Pharmaceutical Co. Ltd.

DAE HWA Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
127,998
134,931
139,080
142,288
122,790
Cost of Goods Sold (COGS) incl. D&A
95,771
95,837
97,185
98,085
75,965
Gross Income
32,227
39,094
41,895
44,203
46,825
SG&A Expense
27,431
34,413
36,053
38,497
37,446
EBIT
4,618
4,515
5,657
5,390
9,023
Non Operating Income/Expense
37
1,837
1,952
48
7,540
Interest Expense
1,706
1,421
1,132
1,171
1,336
Pretax Income
3,279
5,321
6,787
6,071
17,435
Income Tax
1,311
6,478
2,345
2,316
4,469
Equity in Affiliates
57
9
330
-
-
Consolidated Net Income
2,025
1,148
4,111
3,755
12,967
Net Income
1,676
102
3,911
3,729
13,508
Net Income After Extraordinaries
1,676
102
3,911
3,729
13,508
Net Income Available to Common
1,676
102
3,911
3,729
13,508
EPS (Basic)
95.00
6.00
221.00
211.00
764.00
Basic Shares Outstanding
18
18
18
18
18
EPS (Diluted)
95.42
5.78
221.50
211.21
764.31
Diluted Shares Outstanding
18
18
18
18
18
EBITDA
7,926
7,792
9,159
9,201
12,965
Other Operating Expense
178
166
186
315
356
Non-Operating Interest Income
405
389
310
258
283
Minority Interest Expense
349
1,046
200
26
541
Equity in Affiliates (Pretax)
-
-
-
71
225

About DAE HWA Pharmaceutical Co.

View Profile
Address
495 Hanu-ro
Hoengseong-gun GA 25228
Korea, Republic Of
Employees -
Website http://www.dhpharm.co.kr
Updated 09/14/2018
DAE HWA PHARM Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Pharmaceuticals Manufacturing and Distribution, Pharmaceuticals Wholesale, and Pharmaceuticals Materials Manufacturing and Distribution. Its products include cough suppressants, expectorants, and mucolytics, drugs affecting the nervous system, drugs for liver diseases, corticosteroids, and hemorrhoid disease, analgesics, anti-inflammatory, anti-pyretics, vitamins and tonics, plaster, antihistamines, skeletal muscle relaxants, cardiovascular drugs, anti-inflammatory enzymes, gastro-intestinal drugs, iron and calcium supply, topical drugs, and injections.